Arsenic trioxide in patients with hepatocellular carcinoma: a phase II trial

By Lin Chia-Chi   Hsu Chiun   Hsu Chih-Hung   Hsu Wei-Ling   Cheng Ann-Lii   Yang Chih-Hsin  

Investigational New Drugs, Vol. 25, Iss. 1, 2007-02 ,pp. : 77-84

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of darinaparsin in patients with advanced hepatocellular carcinoma

By Wu Jennifer   Henderson Charles   Feun Lynn   Veldhuizen Peter   Gold Philip   Zheng Hui   Ryan Theresa   Blaszkowsky Lawrence   Chen HaoBin   Costa Max   Rosenzweig Barry   Nierodzik MaryLynn   Hochster Howard   Muggia Franco   Abbadessa Giovanni   Lewis Jonathan   Zhu Andrew  

Investigational New Drugs, Vol. 28, Iss. 5, 2010-10 ,pp. : 670-676

Springer Publishing Company

Access to resources Recommend Favorite

Phase 1 trial of S-1 in combination with sorafenib for patients with advanced hepatocellular carcinoma

By Lee Su  

Investigational New Drugs, Vol. 30, Iss. 4, 2012-08 ,pp. : 1540-1547

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of fenretinide in advanced renal carcinoma

By Vaishampayan Ulka   Heilbrun Lance   Parchment Ralph   Jain Vikash   Zwiebel James   Boinpally Ramesh   LoRusso Patricia   Hussain Maha  

Investigational New Drugs, Vol. 23, Iss. 2, 2005-01 ,pp. : 179-185

Springer Publishing Company

Access to resources Recommend Favorite

Phase II Trial of Intra-Arterial Chemotherapy using a Novel Lipophilic Platinum Derivative (SM-11355) in Patients with Hepatocellular Carcinoma

By Okusaka Takuji   Okada Shuichi   Nakanishi Toshio   Fujiyama Shigetoshi   Kubo Yasuhiko  

Investigational New Drugs, Vol. 22, Iss. 2, 2004-04 ,pp. : 169-176

Springer Publishing Company

Access to resources Recommend Favorite